Cancer News and Research

Latest Cancer News and Research

Medicare to cover infusion costs for prostate cancer vaccine, company says

In Medicare news, the drug maker Dendreon says federal officials have said they will pay doctors to administer the drug. Also, policymakers are studying Medigap to see if curbs on those policies could help cut Medicare costs.

23 Nov 2011

Families with chronically ill member less likely to benefit from employer-sponsored insurance

Benefits paid out under employer-sponsored health care plans are less generous to families covering a member with a chronic illness than to families without a chronically ill member, according to a trio of university researchers. The difference is due primarily to higher out-of-pocket expenses for prescription drugs.

23 Nov 2011

Dendritic cells play a novel protective role in pancreas

NYU Langone Medical Center researchers have discovered the novel protective role dendritic cells play in the pancreas. The new study, published in the November issue of journal Gastroenterology, shows dendritic cells can safeguard the pancreas against acute pancreatitis, a sudden dangerous swelling and inflammation of the pancreas gland.

23 Nov 2011

Scientists identify P-Rex1 protein key to movement of melanoblasts

Researchers from UNC Lineberger Comprehensive Cancer Center are part of a team that has identified a protein, called P-Rex1, that is key to the movement of cells called melanoblasts. When these cells experience uncontrolled growth, melanoma develops.

23 Nov 2011

George W. Bush to travel to Africa to raise awareness about cervical, breast cancer

Former President George W. Bush will travel next month with former first lady Laura Bush and officials with the George W. Bush Institute to Tanzania, Zambia and Ethiopia "where they'll visit clinics and meet with governmental and health care leaders ... to raise awareness about cervical and breast cancer, an effort he calls a 'natural extension' of" the PEPFAR program launched during his presidency, the Associated Press reports.

23 Nov 2011

Partnerships, additional funding allow for expansion of PEPFAR to combat cervical cancer

In this post in the Public Health Institute's "Dialogue4Health" blog, Jeffrey Meer, director of PHI's Washington-based advocacy on global health, writes that "a significant expansion of PEPFAR's existing work to combat cervical cancer" through a partnership with the George W. Bush Institute known as Pink Ribbon Red Ribbon (PRRR); a 50 percent increase in the U.S. government's "commitment to screen and treat for this type of cancer from $20 million over five years to $30 million"; and additional funding from Susan G. Komen for the Cure "to expand breast cancer awareness and prevention among the same target population of women receiving care at PEPFAR-funded HIV service sites" has allowed "the wonderfully robust PEPFAR prevention and treatment platform, considered one of the great global health achievements in recent times, to be made available to a whole new type of prevention -- in this case for a non-communicable disease (NCD)."

23 Nov 2011

Celgene to discontinue docetaxel and prednisone plus lenalidomide Phase III trial on CRPC

Celgene International Sàrl, a subsidiary of Celgene Corporation, announced that based on the recommendation from the Data Monitoring Committee (DMC) it will discontinue its pivotal double-blinded Phase III MAINSAIL trial that was designed to evaluate the efficacy and safety of docetaxel and prednisone with or without lenalidomide in patients with castrate-resistant prostate cancer.

23 Nov 2011

Researchers pinpoint cancer-fighting potential in bat plant

In a new study published this month in the Journal of the American Chemical Society, researchers with The University of Texas Health Science Center at San Antonio have pinpointed the cancer-fighting potential in the bat plant, or Tacca chantrieri.

23 Nov 2011

New IOM report assesses breast cancer risk posed by environmental factors

Although women have little or no control over some of the risk factors for breast cancer, such as those related to aging and genetics, they may be able to reduce their chances for developing the disease by avoiding certain environmental risks. BREAST CANCER AND THE ENVIRONMENT: A LIFE COURSE APPROACH, a new report from the Institute of Medicine, assesses the breast cancer risk posed by various environmental factors, identifies actions that offer potential to reduce women's risk for the disease, and recommends targets for future research.

23 Nov 2011

Holiday health tips for cancer survivors

Surviving the holidays with one's waistline, bank account and sanity intact can be challenging for everyone, but the season affords specific pitfalls - and opportunities - for cancer survivors who are mindful of staying healthy throughout the season and beyond.

23 Nov 2011

Defending Washington's basic health plan; Questioning Wisconsin's proposed health care cuts

The Basic Health program has played an important role in extending the safety net to provide coverage to many low-income people who can't afford to purchase coverage on their own and don't qualify for Medicaid. It's much easier to retain an infrastructure than to build a new one from scratch. Simply put, leaving people without health insurance lengthens the recession and imposes costs on us all.

23 Nov 2011

Nine Heidelberg researchers receive European Research Council grants

In the framework of this year's round of the European Research Council's (ERC) competition for outstanding researchers, Heidelberg University has totted up a remarkable score.

23 Nov 2011

State roundup: Calif. retirees to retain health benefits; Emory, MinuteClinic partner in Ga.; Free services in Md.

Health benefits for government retirees may not be eliminated if state and local governments had clearly promised workers those benefits, the California Supreme Court ruled in an Orange County case Monday. The unanimous ruling is expected to make it more difficult for state and local governments to shave costs by cutting health benefits to retirees if elected officials in previous years made it clear that those benefits would last a lifetime.

23 Nov 2011

Biochemists identify structure of hydroxyurea that specifically inhibits proteasome

As the "recycling plant" of the cell, the proteasome regulates vitally important functions. When it is inhibited, the cell chokes on its own waste. Cancer cells, in particular, are very sensitive because they need the proteasome for their uncontrolled growth. Biochemists at the Technische Universitaet Muenchen (TUM) have now identified the lead structure of a new class of drugs that attacks the proteasome in an unusual way. New medication could be developed on the basis of this previously unknown binding mechanism.

22 Nov 2011

Arginine may reactivate T-cells in patients with glioblastoma

In many cases, tumors suppress a patient's immune system in a way that keeps the cancer safe from immune system attack. This is particularly true for patients with glioblastoma, a primary brain tumor that carries a prognosis of only 12-15 months survival after diagnosis.

22 Nov 2011

IsoRay receives Washington State approval for GliaSite system to treat brain cancer

IsoRay, Inc. announced today it has received final approval from the State of Washington Department of Health to manufacture its GliaSite radiation therapy system, a balloon catheter device used in the treatment of brain cancer. In conjunction with the previously announced FDA clearance, the Washington State approval represents IsoRay's final regulatory hurdle to commence the sale of its GliaSite brain cancer treatment in the United States.

22 Nov 2011

FDA accepts Regeneron's ARCALYST sBLA for review

Regeneron Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Company's supplemental Biologics License Application (sBLA) for ARCALYST Injection for Subcutaneous Use for the prevention of gout flares in patients initiating uric acid-lowering therapy.

22 Nov 2011

Virtues of a simple “Thank You” a day

Gratitude is a positive emotion with strong psychological effects say researchers. Now psychologists are trying to figure out the brain chemistry behind gratitude and the best ways of showing it.

22 Nov 2011

Coffee may protect against womb cancer: Study

For the study the researchers looked at coffee consumption and endometrial cancer risk in more than 67,000 women aged between 34 and 59 enrolled in the long-running Nurses' Health Study. The researchers found that women who took more than four cups of coffee a day over a 26-year period were 25 percent less likely to get the cancer.

22 Nov 2011

Post-surgery death risk high among thinner people: Study

A new study has found that thinner people are at a higher risk of dying within 30 days of an operation than heavier people. The cause behind this trend is not clear.

22 Nov 2011

Cancer News and Research

Latest Cancer News and Research

Medicare to cover infusion costs for prostate cancer vaccine, company says

Families with chronically ill member less likely to benefit from employer-sponsored insurance

Dendritic cells play a novel protective role in pancreas

Scientists identify P-Rex1 protein key to movement of melanoblasts

George W. Bush to travel to Africa to raise awareness about cervical, breast cancer

Partnerships, additional funding allow for expansion of PEPFAR to combat cervical cancer

Celgene to discontinue docetaxel and prednisone plus lenalidomide Phase III trial on CRPC

Researchers pinpoint cancer-fighting potential in bat plant

New IOM report assesses breast cancer risk posed by environmental factors

Holiday health tips for cancer survivors

Defending Washington's basic health plan; Questioning Wisconsin's proposed health care cuts

Nine Heidelberg researchers receive European Research Council grants

State roundup: Calif. retirees to retain health benefits; Emory, MinuteClinic partner in Ga.; Free services in Md.

Biochemists identify structure of hydroxyurea that specifically inhibits proteasome

Arginine may reactivate T-cells in patients with glioblastoma

IsoRay receives Washington State approval for GliaSite system to treat brain cancer

FDA accepts Regeneron's ARCALYST sBLA for review

Virtues of a simple “Thank You” a day

Coffee may protect against womb cancer: Study

Post-surgery death risk high among thinner people: Study

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in